Incyte Pharmaceuticals Inc., OncorMed deal

INCY will purchase ONM's clinical genomic services during each year of the agreement for an undisclosed amount, and purchased

Read the full 191 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE